Dr. Wuitschik is a senior scientist in Process Chemistry at Roche. He has worked on a number of early- as well as late-stage small molecule projects after joining Roche in 2011. His work, through external as well as internal resources, cover API process R&D, drug substance manufacturing, and support of regulatory filings.

Dr. Wuitschik received his diploma from Technical University of Munich with a master thesis under supervision of Prof. Barry M. Trost, and Ph.D. from ETH Zurich under the supervision of Prof. Erick M. Carreira under the title Oxetanes in Medicinal Chemistry, followed by a postdoc in the group of Prof. Steve V. Ley at Cambridge University.

With a uniquely broad spectrum of innovative solutions, Roche is a leading healthcare company that has for over 100 years been active in the discovery, development, manufacture and marketing of healthcare solutions. Our products and services address prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life.

Headquartered in Basel Switzerland, Roche employs over 85 000 people globally and sells its products in over 150 countries. Our multinational presence reinforces our ability to offer our healthcare solutions worldwide and to anticipate needs in all regions of the world.